Insulet Corp, known for its Omnipod insulin delivery system, saw a surge in institutional investments, led by Mizuho Securities USA.

Insulet Corp, which makes insulin delivery systems like the Omnipod, saw a big increase in institutional investments during the third quarter. Mizuho Securities USA LLC led the way by boosting its stake by 5,928.1%, now owning $75.8 million worth of shares. Other investors also increased their holdings. The stock, which opened at $260.12 on Friday, has a market cap of $18.25 billion and has received mostly positive ratings from analysts.

November 16, 2024
3 Articles